Structural and biochemical characteristics of mRNA nanoparticles determine anti–SARS-CoV-2 humoral and cellular immune responses

The coronavirus disease 2019 (COVID-19) pandemic underlines the urgent need for effective mRNA vaccines. However, current understanding of the immunological outcomes of mRNA vaccines formulated under different nanoplatforms is insufficient. Here, severe acute respiratory syndrome coronavirus 2 recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yingying, Huang, Jiaxin, Liu, Yu, Liu, Jing, Guo, Xuemeng, Li, Jianhua, Gong, Liming, Zhou, Xin, Cheng, Guofeng, Qiu, Yunqing, You, Jian, Lou, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683711/
https://www.ncbi.nlm.nih.gov/pubmed/36417530
http://dx.doi.org/10.1126/sciadv.abo1827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683711/
https://www.ncbi.nlm.nih.gov/pubmed/36417530
http://dx.doi.org/10.1126/sciadv.abo1827

Ejemplares similares